Tumor surface signature in glioblastoma distinguishes IDH mutant from wildtype high grade glioma and identifies novel targets for immunotherapy

Presenting Author(s)

• 

  Jenny Kienzler, MD PhD

  Senior Researcher and Attending Neurosurgeon
  University of Zurich and University Hospital Lausanne